【レポートの概要（一部）】
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets/Categories Covered 11
3.1 Orthopedic Devices 11
3.1.1 Arthroscopy 11
3.1.2 Spinal Surgery 11
4 Company Snapshot 12
4.1 Key Key Facts 12
4.2 Company Overview 12
4.3 Financial Performance 12
4.4 SWOT Snapshot 12
5 Business Description 13
5.1 Business Overview 13
5.2 Other 13
5.2.1 Overview 13
5.2.2 Financials 13
5.2.3 Market View 13
5.3 Sports Medicine 14
5.3.1 Overview 14
5.3.2 Financials 14
5.3.3 Market View 14
5.4 Major Products and Services 14
5.4.1 Overview 14
6 History 16
7 Business Strategy 18
7.1 Mission Statement 18
8 SWOT Analysis 19
8.1 Overview 19
8.2 ArthroCare Corporation Strengths 19
8.2.1 Focus on Research and Development Activities 19
8.2.2 Proprietary Coblation Technology 19
8.2.3 Diversified Operations 20
8.3 ArthroCare Corporation Weaknesses 20
8.3.1 Dependence on the US Market 20
8.3.2 Governmental Investigations 20
8.3.3 Decline in Current Asset Turnover 21
8.4 ArthroCare Corporation Opportunities 21
8.4.1 Product Approvals 21
8.4.2 Growth in Arthroscopy Market 21
8.4.3 Growing Spinal Surgery Procedures 21
8.4.4 Market Growth in Emerging Economies 22
8.5 ArthroCare Corporation Threats 22
8.5.1 Stringent Government Regulations 22
8.5.2 Competitive Landscape 22
8.5.3 Dependent on Few Suppliers 22
8.5.4 Growing Consolidation in the Industry 22
9 Competitors 23
10 Competitive Landscape 24
10.1 Orthopedic Devices (Spinal Surgery), Global, Market Share (%), 2011 24
10.2 ArthroCare Corporation, Orthopedic Devices (Spinal Surgery), by Region, Market Share (2011) 26
10.3 ArthroCare Corporation, Orthopedic Devices (Spinal Surgery), by Country, Market Share (2011) 27
10.4 Orthopedic Devices (Arthroscopy), Global, Market Share (%), 2011 28
10.5 ArthroCare Corporation, Orthopedic Devices (Arthroscopy), by Region, Market Share (2011) 29
10.6 ArthroCare Corporation, Orthopedic Devices (Arthroscopy), by Country, Market Share (2011) 30
11 Share Holding Structure 32
12 Key Employees 33
13 Key Employee Biographies 34
14 Company Statement 35
15 Locations And Subsidiaries 38
15.1 Head Office 38
15.2 Other Locations & Subsidiaries 38
16 Financial Deals Landscape 40
16.1 ArthroCare Corporation, Deals Volume Summary, 2007 to YTD 2013 40
17 ArthroCare Corporation, Deals Summary By Region, 2007 to YTD 2013 41
18 ArthroCare Corporation Detailed Deal Summary 43
18.1 Partnerships 43
18.1.1 Wright Medical Enters Into Distribution Agreement With ArthroCare 43
18.2 Equity Offering 44
18.2.1 ArthroCare Completes Private Placement Of $75 Million 44
18.3 Asset Transactions 46
18.3.1 NeuroTherm Acquires Parallax And Contour Product Lines From ArthroCare 46
18.4 Acquisition 47
18.4.1 ArthroCare Acquires OrtoConcept 47
18.4.2 ArthroCare Acquires DiscoCare 48
19 Recent Developments 49
19.1 Financial Announcements 49
19.1.1 Oct 31, 2012: ArthroCare Reports Revenue Of $86.9m In Q3 2012 49
19.1.2 Aug 01, 2012: ArthroCare Reports Revenue Of $91.7m In Q2 2012 50
19.1.3 May 02, 2012: ArthroCare Reports Revenue Of $92.9m In Q1 2012 51
19.1.4 Feb 16, 2012: ArthroCare Reports Revenue Of $354.9m In 2011 52
19.1.5 Nov 02, 2011: ArthroCare Reports Revenues Of $83.3m In Q3 2011 54
19.1.6 Aug 03, 2011: ArthroCare Reports Total Revenue Of $91.3m In Q2 2011 55
19.1.7 May 02, 2011: ArthroCare Reports Total Revenue Of $87.9m In Q1 2011 56
19.1.8 Feb 14, 2011: ArthroCare Reports Total Revenues Of $355.38m In 2010 58
19.1.9 Nov 01, 2010: ArthroCare Reports Net Income Of $9.26 Million For Q3 2010 58
19.1.10 Aug 03, 2010: ArthroCare Reports Net Income Of $7.27 Million In Q2 2010 59
19.1.11 May 05, 2010: ArthroCare Reports Net Income Of $8.8 Million In Q1 2010 60
19.1.12 Mar 15, 2010: ArthroCare Reports Total Revenues Of $331.6 Million In 2009 61
19.1.13 Nov 24, 2009: ArthroCare Reports Total Revenues Of $79.5 Million In Q3 2009 62
19.1.14 Nov 19, 2009: ArthroCare Reports Revenue Of $80.8 Million For Q2 2009 64
19.1.15 Apr 21, 2008: ArthroCare Declares Q1 2008 Results 64
19.1.16 Feb 26, 2008: ArthroCare Board Extends Share Repurchase Plan 66
19.1.17 Feb 19, 2008: ArthroCare Declares Q4 2007 Results 66
19.1.18 Oct 22, 2007: ArthroCare Declares Q3 2007 Results 68
19.1.19 Jul 26, 2007: ArthroCare Declares Q2 2007 Results 70
19.1.20 Apr 26, 2007: ArthroCare Q1 Revenue Up 18% To $73.7 Million 71
19.1.21 Feb 15, 2007: ArthroCare Q4 Revenue Up 18% To $69.8 Million 71
19.1.22 Jan 09, 2007: ArthroCare Sees Q4 2006 Revenues At $69.7 Million 73
19.1.23 Oct 26, 2006: ArthroCare Q3 2006 Total Revenue Up 21% To $64.7 Million 74
19.1.24 Aug 03, 2006: ArthroCare Q2 2006 Revenue Up 28% To $51.7 Million 75
19.2 Corporate Communications 78
19.2.1 Jan 19, 2010: ArthroCare Shares To Begin Trading Oon NASDAQ Global Market 78
19.2.2 Jan 04, 2010: ArthroCare Appoints Scott Schaffner As Senior Vice President And General Manager Of Sports Medicine 78
19.2.3 Oct 26, 2009: ArthroCare Appoints David Fitzgerald As President, CEO 78
19.2.4 Jul 01, 2009: ArthroCare Appoints Andrew Miclot As SVP, General Manager Of ENT Business 79
19.2.5 Apr 02, 2009: ArthroCare Names Todd Newton As Senior Vice President, CFO 79
19.2.6 Feb 18, 2009: ArthroCare Announces Management Changes 80
19.2.7 Jan 15, 2009: ArthroCare Gets Nasdaq Delisting Notice 80
19.2.8 Dec 19, 2008: ArthroCare Announces Management Resignations 80
19.2.9 Dec 19, 2008: ArthroCare Announces Senior Management Promotions 81
19.2.10 Dec 01, 2008: ArthroCare Announces Decision From NASDAQ Granting Its Request For Continued Listing 81
19.2.11 Nov 18, 2008: ArthroCare Receives Deficiency Notice From Nasdaq 81
19.2.12 Dec 14, 2006: ArthroCare Expands Board 82
19.3 Legal and Regulatory 82
19.3.1 Aug 22, 2012: Two Former Senior Executives of ArthroCare Arrested In $400m Securities Fraud Scheme 82
19.3.2 Nov 28, 2011: ArthroCare Announces Agreement In Principle To Settle Securities Class Action 84
19.3.3 Feb 09, 2011: ArthroCare Announces Settlement Of SEC Investigation 84
19.3.4 Mar 04, 2010: Arthrocare Enters Settlement Agreement With Nationwide In Reimbursement Dispute 84
19.3.5 Dec 08, 2009: ArthroCare To Pay About $1 Million To Settle With Several Insurers Over SpineWand Reimbursement Claims 85
19.3.6 Feb 18, 2009: ArthroCare Announces Investigations By SEC And US Attorney Offices 85
19.3.7 Jul 24, 2008: ArthroCare Says SEC Starts Informal Inquiry Into Accounting Practices After Restatement 85
19.3.8 Apr 07, 2008: Sarraf Files Lawsuit Against ArthroCare 85
19.4 Product News 86
19.4.1 Aug 15, 2011: ArthroCare Receives FDA Clearance For SpeedLock Knotless Fixation Device 86
19.4.2 Jul 26, 2011: ArthroCare Receives FDA Clearance For SpeedFix Suture System 86
19.4.3 Jun 06, 2011: ArthroCare Receives FDA Clearance For Spartan 6.5 Needled Suture Implant 86
19.4.4 Feb 22, 2011: ArthroCare Receives FDA Clearance For Parallax Contour -Enhanced Vertebral Augmentation Device 87
19.4.5 Feb 15, 2011: ArthroCare Receives FDA Clearance For Spartan 5.5 Needled Suture Implant 87
19.4.6 Dec 09, 2010: ArthroCare Receives CE Mark Approval For WoundWand Debridement Device 87
19.4.7 Nov 02, 2010: ArthroCare Receives FDA Clearance For SpeedFix 87
19.4.8 Oct 28, 2010: ArthroCare Receives FDA Clearance For Spartan PEEK Suture Implant 88
19.4.9 Sep 24, 2010: ArthroCare Receives FDA Clearance For Parallax Contour Vertebral Augmentation Device 88
19.4.10 Sep 24, 2008: New Studies Highlight Benefits Of Coblation-Assisted Procedures In Airway Fire Prevention And Endoscopic Sinus Surgery 88
19.4.11 Jun 23, 2008: Two Studies At World Oncology Conference Support ArthroCare SpineWand 89
19.4.12 Jun 19, 2008: ArthroCare Corporation (ARTC) Launches DoublePlay New Osteoconductive Suture Anchor 89
19.4.13 Jun 19, 2008: ArthroCare Corporation (ARTC) Sets New Standard In Modern Arthroscopy Launches New Quantum Pump Arthroscopy System 90
19.4.14 May 07, 2008: Patients Treated For Chronic Tendinosis With TOPAZ Highly Satisfied Study Shows 90
19.4.15 Apr 10, 2008: ArthroCare Announces Parallax Contour, A New Device For Mechanical Void Creation 91
19.4.16 Apr 03, 2008: ArthroCare Unveils New Direction In Treatment Of Metastatic Lesions 91
19.4.17 Oct 30, 2007: ArthroCare Launches Opus TwinLock Knotless Fixation System 92
19.4.18 Oct 23, 2007: ArthroCare Releases New SpineWand For Less Invasive Spinal Surgeries 92
19.4.19 May 22, 2007: Two Studies Indicate Coblation Safely Treats Symptomatic Chondral Defects in the Knee 92
19.4.20 May 15, 2007: ArthroCare Receives FDA Clearance to Treat Malignant Lesions in the Spine 93
19.4.21 Apr 26, 2007: ArthroCare Receives FDA Clearance To Market Magnum PI Knotless Implant System 93
19.4.22 Apr 27, 2006: Study Results Show Coblation Technology Preserves Same Amount of Healthy Cells as Mechanical Shaver in Treatment of Meniscus 93
19.4.23 Mar 30, 2006: ArthroCare Receives FDA Clearance for Latest Vertebroplasty Innovation to Help Treat Vertebral Compression Fractures 94
19.4.24 Aug 03, 2005: ArthroCare’s TOPAZ Named Among Podiatry Today’s Annual Top Ten Innovations List. 94
19.4.25 Nov 03, 2004: Live Webcast On Minimally Invasive Tendon And Fascia Treatments To Feature ArthroCare’s TOPAZ Microdebrider 94
19.4.26 Apr 28, 2004: ArthroCare introduced two new SpineWands 94
19.4.27 Oct 15, 2003: Bilok(R) for ACL Fixation Now Available in United States 95
19.4.28 Apr 01, 2000: Arthrocare’s Coblation System To Be Used For Brain Surgery 95
19.5 Product Approvals 95
19.5.1 Aug 15, 2011: ArthroCare Receives FDA Clearance For SpeedLock Knotless Fixation Device 95
19.5.2 Jul 26, 2011: ArthroCare Receives FDA Clearance For SpeedFix Suture System 95
19.5.3 Jun 06, 2011: ArthroCare Receives FDA Clearance For Spartan 6.5 Needled Suture Implant 96
19.5.4 Feb 22, 2011: ArthroCare Receives FDA Clearance For Parallax Contour -Enhanced Vertebral Augmentation Device 96
19.5.5 Feb 15, 2011: ArthroCare Receives FDA Clearance For Spartan 5.5 Needled Suture Implant 96
19.5.6 Dec 09, 2010: ArthroCare Receives CE Mark Approval For WoundWand Debridement Device 97
19.5.7 Nov 02, 2010: ArthroCare Receives FDA Clearance For SpeedFix 97
19.5.8 Oct 28, 2010: ArthroCare Receives FDA Clearance For Spartan PEEK Suture Implant 97
19.5.9 Sep 24, 2010: ArthroCare Receives FDA Clearance For Parallax Contour Vertebral Augmentation Device 97
19.5.10 May 15, 2007: ArthroCare Receives FDA Clearance to Treat Malignant Lesions in the Spine 98
19.5.11 Apr 26, 2007: ArthroCare Receives FDA Clearance To Market Magnum PI Knotless Implant System 98
19.5.12 Mar 30, 2006: ArthroCare Receives FDA Clearance for Latest Vertebroplasty Innovation to Help Treat Vertebral Compression Fractures 98
19.6 Clinical Trials 99
19.6.1 Sep 24, 2008: New Studies Highlight Benefits Of Coblation-Assisted Procedures In Airway Fire Prevention And Endoscopic Sinus Surgery 99
19.6.2 May 07, 2008: Patients Treated For Chronic Tendinosis With TOPAZ Highly Satisfied Study Shows 99
20 Appendix 101
20.1 Research Methodology 102
20.2 Secondary Research 102
20.3 Primary Research 102
20.4 Models 103
20.5 Forecasts 103
20.6 Expert Panels 103
20.7 GlobalData Consulting 103
20.8 Currency Conversion 104
20.9 Contact Us 105
20.10 Disclaimer 105
【レポート販売概要】
■ タイトル：ArthroCare Corporation：市場シェア分析■ 英文：ArthroCare Corporation Market Share Analysis
■ 発行日：2013年2月28日
■ 調査会社：GlobalData
■ 商品コード：GDATA403160473
■ 調査対象地域：グローバル
- o-キシレン（Orthoxylene）の世界市場：無水フタル酸用途About Orthoxylene Orthoxylene is a compound used for making phthalic anhydride, an aromatic acid anhydride. Almost 90-95 percent of orthoxylene produced worldwide is used in the manufacturing of phthalic anhydride, which is commercially available as white, free-flowing fragments or colourless molten material with a pungent smell. Phthalic anhydride is used in the manufacture of plasticizers such a …
- 配矯正装置の世界市場分析：用途別（股関節、膝、脊柱、頭蓋 – 顎顔面、歯科、スポーツ外傷、外傷、外傷（SET））、製品タイプ別（アクセサリー、外科装置）、セグメント予測The global orthopedic devices market is expected to reach USD 43.1 billion by 2024, according to a new report published by Grand View Research, Inc. Major drivers of the market include the rising demand for orthopedic surgeries owing to the growth in road accidents and the prevalence of orthopedic diseases. The introduction of new products made of materials, such as various types of ceramics and p …
- データ品質管理ツールの世界市場2015-2019About Data Quality Tools Data quality tools refer to the wide range of tools required for ensuring quality and reliability of data in various business processes including core business operations, BI, analytics, and decision making. The data quality vendors offer a wide range of functionalities including data profiling, monitoring, parsing, standardization, and data enrichment. These tools are app …
- 量子ドットディスプレイの世界市場：UHDテレビ、スマートフォン、タブレットPCTechnavio’s research analyst predicts the global quantum dots display market to grow steadily at a CAGR of 76% during the forecast period. Quantum dots are semiconductor nanocrystals having dimensions less than 10nm. They are used in various applications such as healthcare, display, LED lighting, and solar cells. In display applications, quantum dots are used only to filter light from LEDs to back …
- Consol Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Consol Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Consol Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- ウォッカの世界市場2015-2019About Vodka Vodka is a mixture of purified water and rectified ethyl alcohol. Vodka is traditionally the product of distillation of fermented grains or potatoes. However, these days many modern brands use other substances such as fruits or sugar. Technavio's analysts forecast the global vodka market to grow at a CAGR of 0.2% in terms of volume and 2.1% in terms of revenue over the period 2014-2019 …
- ナイトビジョンデバイスの世界市場：カメラ、スコープ、ゴーグルIn this report, the global night vision device market has been broadly classified on the basis of device type, technology type, application, and geography. The major device types include night vision cameras, night vision goggles, and night vision scopes. The night vision camera segment is expected to be the fastest-growing segment in the overall market, projected to grow at the fastest CAGR of 11 …
- 医療機器業界のM&A及び投資動向（月別）：March 2013Medical Equipment Monthly Deals Analysis: March 2013- M&A and Investment Trends Summary GlobalData's “Medical Equipment Monthly Deals Analysis: March 2013- M&A and Investment Trends” report is an essential source of data and trend analysis on the mergers and acquisitions (M&As) and financings in the medical equipment industry. The report provides detailed information on M&As, equity/debt offerings …
- 高等教育ソリューションの世界市場2016-2020About Higher Education Nations have begun to understand the need to retain their competitive edge by developing and sustaining a skilled workforce. In this context, higher education plays a critical role in the innovation and development of efficient human capital, which in turn will play a crucial role in the success and sustainability of the economy. Higher education institutes have been continu …
- Gamma oryzanolの世界市場Gamma oryzanol (CAS 11042-64-1) Market Research Report 2013 presents comprehensive data on gamma oryzanol markets globally and regionally (Europe, Asia, North America etc.) The report includes gamma oryzanol description, covers its application areas and related patterns. It overviews gamma oryzanol market, names gamma oryzanol producers and indicates its suppliers. Besides, the report provides gam …
- 世界の廃棄物エネルギー転換(Waste to Energy)技術市場動向（2012-2016）TechNavio's analysts forecast the Global Waste to Energy Technologies market to grow at a CAGR of 5.35 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing environmental concerns. The Global Waste to Energy Technologies market has also been witnessing the increased interdependence of WTE plants and hydrogen plants. However, the availability …
- イギリスの気道装置・麻酔装置市場United Kingdom Airway and Anesthesia Devices Market Outlook to 2021 Summary GlobalData’s new report, "United Kingdom Airway and Anesthesia Devices Market Outlook to 2021", provides key market data on the United Kingdom Airway and Anesthesia market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Anesthesia Cir …
- Ivoclar Vivadent AG：市場シェア分析Ivoclar Vivadent AG Market Share Analysis Summary GlobalData’s new report, “Ivoclar Vivadent AG Market Share Analysis” provides in-depth information on Ivoclar Vivadent AG’s market position in the different medical equipment markets it operates in. The report provides Ivoclar Vivadent AG market share information in two key market categories – Crowns and Bridges and Dental Lasers. The report also p …
- アセトンの世界市場動向及び予測2015The present report is an essential resource for a one looking for detailed information on the world acetone market. The report covers data on global, regional and national markets including present and future trends for supply and demand, prices, and downstream industries. In addition to the analytical part, the report provides a range of tables and figures which all together give a true insight i …
- マグネシウムの世界市場2018-2022About magnesium Magnesium is present in over 60 minerals but only dolomite, magnesite, brucite, carnallite, and olivine are used commercially. Technavio’s analysts forecast the Global magnesium market to grow at a CAGR of 5.92% during the period 2018-2022. Covered in this report The report covers the present scenario and the growth prospects of the magnesium market. To calculate the market size, t …
